Feedback / Questions
Krazati (adagrasib) - BMS
Erbitux (cetuximab) - Eli Lilly, EMD Serono
Libtayo (cemiplimab-rwlc) - Regeneron
http://clinicaltrials.gov/ct2/show/NCT06412198
May 14, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next